HYDROXYUREA

HYDROXYUREA was reported 21340 times

HYDROXYUREA is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 GRANULOMATOUS ROSACEA 14 0.2857
1 ACUTE CHEST SYNDROME 176 0.2002
2 ANGIODERMATITIS 15 0.1765
3 DIFFERENTIATION SYNDROME 102 0.1390
4 ESSENTIAL THROMBOCYTHAEMIA 47 0.1274
5 LEUKOSTASIS SYNDROME 15 0.1128
6 PRIMARY MYELOFIBROSIS 32 0.0994
7 SICKLE CELL ANAEMIA WITH CRISIS 1503 0.0953
8 NAIL PIGMENTATION 23 0.0950
9 MYELOFIBROSIS 275 0.0908
10 SICKLE CELL DISEASE 41 0.0887
11 MYELOPROLIFERATIVE NEOPLASM 52 0.0784
12 POLYCYTHAEMIA VERA 57 0.0696
13 HYPERLEUKOCYTOSIS 59 0.0666
14 SICKLE CELL ANAEMIA 39 0.0605
15 BLAST CRISIS IN MYELOGENOUS LEUKAEMIA 74 0.0600
16 ERYTHROMELALGIA 20 0.0546
17 BLAST CELL COUNT INCREASED 56 0.0534
18 CYTOGENETIC ANALYSIS ABNORMAL 55 0.0525
19 PLATELET COUNT INCREASED 657 0.0503
20 PHILADELPHIA CHROMOSOME POSITIVE 34 0.0465
21 BONE MARROW RETICULIN FIBROSIS 12 0.0465
22 CHRONIC MYELOID LEUKAEMIA TRANSFORMATION 20 0.0448
23 TRANSFORMATION TO ACUTE MYELOID LEUKAEMIA 29 0.0442
24 ERYTHROPOIESIS ABNORMAL 12 0.0392
25 HYPERSPLENISM 19 0.0384
26 SPLENOMEGALY 433 0.0369
27 CHRONIC MYELOMONOCYTIC LEUKAEMIA 24 0.0364
28 CHRONIC MYELOID LEUKAEMIA 168 0.0364
29 MYELOID LEUKAEMIA 18 0.0359
30 THROMBOCYTOSIS 130 0.0354
31 CHRONIC MYELOID LEUKAEMIA RECURRENT 19 0.0347
32 MARROW HYPERPLASIA 22 0.0323
33 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 23 0.0314
34 HAEMATOCRIT INCREASED 69 0.0302
35 THROMBOCYTHAEMIA 16 0.0288
36 BLAST CELLS PRESENT 13 0.0270
37 MYELODYSPLASTIC SYNDROME TRANSFORMATION 14 0.0269
38 BLOOD IRON INCREASED 49 0.0261
39 HAEMATOCRIT ABNORMAL 32 0.0260
40 RETICULOCYTE COUNT INCREASED 21 0.0260
41 SPLENIC INFARCTION 45 0.0258
42 SERUM FERRITIN INCREASED 136 0.0258
43 ACTINIC KERATOSIS 66 0.0254
44 FULL BLOOD COUNT INCREASED 30 0.0252
45 SPLEEN DISORDER 40 0.0236
46 ACUTE LEUKAEMIA 37 0.0229
47 ANISOCYTOSIS 15 0.0228
48 ACUTE MYELOID LEUKAEMIA 352 0.0226
49 INCREASED VISCOSITY OF UPPER RESPIRATORY SECRETION 16 0.0209
50 GRAFT VERSUS HOST DISEASE IN SKIN 45 0.0204
51 RED BLOOD CELL COUNT INCREASED 55 0.0199
52 BASOPHIL COUNT INCREASED 15 0.0198
53 PLATELET COUNT ABNORMAL 118 0.0195
54 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 18 0.0195
55 TUMOUR LYSIS SYNDROME 168 0.0191
56 IRON OVERLOAD 19 0.0176
57 ACUTE MYELOID LEUKAEMIA RECURRENT 37 0.0172
58 RED BLOOD CELL COUNT ABNORMAL 24 0.0163
59 HAEMOGLOBIN INCREASED 74 0.0162
60 EXTREMITY NECROSIS 28 0.0160
61 SEPTIC EMBOLUS 13 0.0156
62 WHITE BLOOD CELL COUNT INCREASED 596 0.0155
63 CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN 14 0.0151
64 PARAINFLUENZAE VIRUS INFECTION 23 0.0151
65 SQUAMOUS CELL CARCINOMA OF SKIN 90 0.0149
66 ANAEMIA MACROCYTIC 31 0.0145
67 PACKED RED BLOOD CELL TRANSFUSION 19 0.0144
68 URETEROLITHIASIS 15 0.0143
69 LEUKAEMIA RECURRENT 24 0.0142
70 NAIL DISCOLOURATION 55 0.0140
71 LEUKOCYTOSIS 251 0.0139
72 SQUAMOUS CELL CARCINOMA 129 0.0137
73 HEPATOSPLENOMEGALY 35 0.0136
74 CYTOMEGALOVIRUS INFECTION REACTIVATION 60 0.0136
75 PLATELET DISORDER 34 0.0135
76 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 28 0.0131
77 TRISOMY 21 16 0.0127
78 TRANSPLANT FAILURE 30 0.0122
79 DERMATOMYOSITIS 31 0.0122
80 MEAN CELL VOLUME INCREASED 30 0.0117
81 BLOOD LACTATE DEHYDROGENASE INCREASED 184 0.0116
82 SKIN ULCER 295 0.0114
83 DIFFERENTIAL WHITE BLOOD CELL COUNT ABNORMAL 19 0.0112
84 MACROCYTOSIS 13 0.0112
85 BLOOD URIC ACID INCREASED 62 0.0107
86 JUGULAR VEIN THROMBOSIS 19 0.0107
87 EARLY SATIETY 20 0.0103
88 HYPERPHOSPHATAEMIA 22 0.0102
89 TONGUE NEOPLASM MALIGNANT STAGE UNSPECIFIED 17 0.0101
90 PLATELET TRANSFUSION 13 0.0101
91 BLOOD COUNT ABNORMAL 152 0.0100
92 ADENOVIRUS INFECTION 29 0.0100
93 BONE MARROW DISORDER 30 0.0099
94 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 23 0.0099
95 WHITE BLOOD CELL COUNT ABNORMAL 63 0.0099
96 HAEMOGLOBIN ABNORMAL 63 0.0098
97 SPLENIC RUPTURE 16 0.0097
98 STENOTROPHOMONAS INFECTION 13 0.0096
99 WHITE BLOOD CELL DISORDER 25 0.0093
100 SECOND PRIMARY MALIGNANCY 77 0.0092
101 HAEMOGLOBIN DECREASED 947 0.0092
102 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 13 0.0092
103 GENE MUTATION 18 0.0091
104 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 25 0.0090
105 BONE MARROW TRANSPLANT 17 0.0090
106 HAEMATOCRIT DECREASED 177 0.0089
107 LEUKAEMIA 83 0.0088
108 VENOOCCLUSIVE DISEASE 22 0.0088
109 HYPERURICAEMIA 36 0.0088
110 NEUTROPENIC COLITIS 18 0.0087
111 FULL BLOOD COUNT ABNORMAL 89 0.0084
112 RED BLOOD CELL COUNT DECREASED 239 0.0084
113 ACUTE GRAFT VERSUS HOST DISEASE 37 0.0081
114 ENTEROCOCCAL INFECTION 38 0.0079
115 PRIAPISM 27 0.0078
116 BILIRUBIN CONJUGATED INCREASED 18 0.0077
117 SOFT TISSUE INFECTION 14 0.0076
118 PRURITUS GENITAL 18 0.0076
119 SERUM FERRITIN DECREASED 13 0.0075
120 PORTAL VEIN THROMBOSIS 24 0.0074
121 MONOCYTE COUNT INCREASED 26 0.0072
122 LUNG CONSOLIDATION 20 0.0071
123 APLASIA 14 0.0071
124 IDIOPATHIC INTRACRANIAL HYPERTENSION 16 0.0071
125 GRAFT VERSUS HOST DISEASE 51 0.0071
126 RED CELL DISTRIBUTION WIDTH INCREASED 29 0.0070
127 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 18 0.0070
128 CYTOPENIA 85 0.0069
129 TONGUE ULCERATION 23 0.0068
130 BACTERIAL SEPSIS 22 0.0067
131 MIXED LIVER INJURY 20 0.0066
132 VARICES OESOPHAGEAL 20 0.0066
133 PLATELET COUNT DECREASED 704 0.0066
134 PNEUMONIA FUNGAL 26 0.0066
135 VENTRICULAR HYPOKINESIA 21 0.0065
136 MYELODYSPLASTIC SYNDROME 94 0.0065
137 FEBRILE NEUTROPENIA 431 0.0065
138 HEPATOMEGALY 63 0.0064
139 BLOOD DISORDER 51 0.0064
140 BASAL CELL CARCINOMA 99 0.0063
141 APLASTIC ANAEMIA 33 0.0063
142 POLYCYTHAEMIA 13 0.0063
143 EMERGENCY CARE 19 0.0063
144 PULMONARY ALVEOLAR HAEMORRHAGE 35 0.0062
145 SUBDURAL HAEMORRHAGE 17 0.0062
146 TRANSFUSION 65 0.0062
147 CHRONIC GRAFT VERSUS HOST DISEASE 22 0.0061
148 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 58 0.0061
149 MUCOSAL INFLAMMATION 158 0.0060
150 BRONCHOPULMONARY ASPERGILLOSIS 46 0.0059
151 PANCYTOPENIA 329 0.0059
152 NEUTROPHIL COUNT INCREASED 59 0.0058
153 INCREASED TENDENCY TO BRUISE 53 0.0058
154 DISSEMINATED INTRAVASCULAR COAGULATION 81 0.0057
155 BONE MARROW FAILURE 114 0.0056
156 STEM CELL TRANSPLANT 14 0.0056
157 FOETAL GROWTH RESTRICTION 34 0.0056
158 DISCOURAGEMENT 13 0.0056
159 ANAEMIA 1059 0.0055
160 FIBROSIS 17 0.0055
161 LUNG INFILTRATION 48 0.0054
162 CYTOLYTIC HEPATITIS 18 0.0054
163 HYPERBILIRUBINAEMIA 56 0.0054
164 HEPATITIS FULMINANT 16 0.0054
165 THROMBOCYTOPENIA 602 0.0054
166 HYPERSENSITIVITY VASCULITIS 14 0.0053
167 HAEMOLYSIS 41 0.0053
168 ACUTE RESPIRATORY FAILURE 102 0.0053
169 BLOOD LOSS ANAEMIA 12 0.0053
170 PRODUCT AVAILABILITY ISSUE 119 0.0052
171 MULTIPLE-DRUG RESISTANCE 16 0.0052
172 ESCHERICHIA BACTERAEMIA 12 0.0051
173 FULL BLOOD COUNT DECREASED 102 0.0051
174 HAEMORRHAGIC DIATHESIS 18 0.0051
175 CONCOMITANT DISEASE AGGRAVATED 31 0.0050
176 BRAIN HERNIATION 15 0.0050
177 CORONAVIRUS INFECTION 33 0.0050
178 NORMAL NEWBORN 27 0.0050
179 WOUND COMPLICATION 17 0.0049
180 CAROTID ARTERY OCCLUSION 18 0.0049
181 DRUG RESISTANCE 126 0.0049
182 IRON DEFICIENCY 22 0.0049
183 BLOOD IRON DECREASED 58 0.0049
184 PRODUCT USE COMPLAINT 76 0.0048
185 SUBDURAL HAEMATOMA 69 0.0048
186 EPSTEIN-BARR VIRUS INFECTION 30 0.0048
187 NIGHT SWEATS 154 0.0048
188 SKIN HYPERPIGMENTATION 41 0.0048
189 KLEBSIELLA INFECTION 24 0.0047
190 PIGMENTATION DISORDER 29 0.0047
191 CACHEXIA 24 0.0047
192 VENOOCCLUSIVE LIVER DISEASE 23 0.0047
193 PULMONARY HAEMORRHAGE 36 0.0046
194 NEUTROPHILIA 26 0.0046
195 HAEMATOLOGICAL MALIGNANCY 13 0.0046
196 PORTAL HYPERTENSION 14 0.0045
197 HAEMORRHAGE SUBCUTANEOUS 16 0.0045
198 BLOOD BILIRUBIN INCREASED 121 0.0045
199 BK VIRUS INFECTION 15 0.0044
200 ACUTE RESPIRATORY DISTRESS SYNDROME 78 0.0044
201 VASCULITIS 51 0.0044
202 PULMONARY HYPERTENSION 91 0.0044
203 HAEMOLYTIC ANAEMIA 39 0.0043
204 ULCER 69 0.0043
205 GANGRENE 26 0.0043
206 PERICARDIAL EFFUSION 99 0.0043
207 FLANK PAIN 40 0.0043
208 NASAL POLYPS 21 0.0043
209 DECREASED ACTIVITY 46 0.0043
210 ACUTE LYMPHOCYTIC LEUKAEMIA 12 0.0042
211 SKIN CANCER 90 0.0042
212 OCULAR ICTERUS 18 0.0041
213 ESCHERICHIA SEPSIS 12 0.0041
214 BACTERAEMIA 49 0.0041
215 PLEURAL EFFUSION 249 0.0041
216 AORTIC STENOSIS 14 0.0040
217 BLOOD UREA INCREASED 67 0.0040
218 MUSCLE HAEMORRHAGE 16 0.0040
219 CEREBROVASCULAR DISORDER 12 0.0040
220 EMBOLISM VENOUS 12 0.0040
221 BLOOD ALKALINE PHOSPHATASE INCREASED 97 0.0039
222 ENDOCARDITIS 20 0.0039
223 PERIPHERAL VASCULAR DISORDER 20 0.0039
224 LEFT VENTRICULAR DYSFUNCTION 26 0.0039
225 BLOOD POTASSIUM INCREASED 63 0.0039
226 CEREBRAL HAEMATOMA 13 0.0039
227 LEFT VENTRICULAR FAILURE 13 0.0038
228 FEBRILE BONE MARROW APLASIA 16 0.0038
229 ENERGY INCREASED 22 0.0037
230 PRODUCT DOSE OMISSION 242 0.0037
231 GLOSSITIS 13 0.0037
232 IMMUNODEFICIENCY 54 0.0036
233 RALES 21 0.0036
234 SKIN MASS 24 0.0036
235 CARDIAC MURMUR 31 0.0036
236 HAEMATOMA 91 0.0035
237 CLOSTRIDIUM DIFFICILE COLITIS 37 0.0035
238 SKIN NECROSIS 18 0.0035
239 INTERNATIONAL NORMALISED RATIO DECREASED 14 0.0035
240 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 14 0.0034
241 CARDIOMEGALY 42 0.0034
242 MOUTH HAEMORRHAGE 25 0.0034
243 CONJUNCTIVAL HAEMORRHAGE 13 0.0034
244 LIPASE INCREASED 26 0.0034
245 CYTOMEGALOVIRUS VIRAEMIA 15 0.0034
246 BLOOD TEST ABNORMAL 47 0.0033
247 GOUT 60 0.0033
248 RHINOVIRUS INFECTION 13 0.0033
249 WHITE BLOOD CELL COUNT DECREASED 362 0.0033
250 HYDRONEPHROSIS 25 0.0033
251 PHLEBITIS 17 0.0033
252 GENERALISED OEDEMA 41 0.0033
253 CYTOMEGALOVIRUS INFECTION 55 0.0033
254 CARDIAC FAILURE ACUTE 22 0.0033
255 EPISTAXIS 247 0.0033
256 MULTIPLE ORGAN DYSFUNCTION SYNDROME 93 0.0033
257 CEREBRAL ATROPHY 13 0.0033
258 CREATININE RENAL CLEARANCE DECREASED 13 0.0032
259 THERAPY NON-RESPONDER 146 0.0032
260 HYPOMAGNESAEMIA 45 0.0032
261 CYSTITIS HAEMORRHAGIC 13 0.0032
262 OLIGURIA 20 0.0032
263 STAPHYLOCOCCAL BACTERAEMIA 14 0.0032
264 DYSPNOEA EXERTIONAL 121 0.0032
265 PLEURISY 19 0.0032
266 ELECTROCARDIOGRAM QT PROLONGED 115 0.0032
267 HAEMORRHAGIC ANAEMIA 14 0.0032
268 PERIPHERAL ISCHAEMIA 13 0.0032
269 MOUTH ULCERATION 67 0.0032
270 CHOLESTASIS 61 0.0032
271 PSEUDOMONAS INFECTION 27 0.0031
272 CONTUSION 303 0.0031
273 INTENTIONAL PRODUCT USE ISSUE 274 0.0031
274 LABORATORY TEST ABNORMAL 92 0.0031
275 NO THERAPEUTIC RESPONSE 38 0.0031
276 MITRAL VALVE INCOMPETENCE 35 0.0031
277 RETINAL HAEMORRHAGE 22 0.0031
278 HYPERKERATOSIS 17 0.0031
279 INTERSTITIAL LUNG DISEASE 149 0.0031
280 HAEMORRHAGE INTRACRANIAL 46 0.0031
281 INSURANCE ISSUE 47 0.0031
282 BONE PAIN 180 0.0031
283 ECCHYMOSIS 21 0.0031
284 THERAPY CESSATION 157 0.0031
285 CEREBRAL HAEMORRHAGE 109 0.0030
286 BLOOD ALBUMIN DECREASED 24 0.0030
287 GINGIVAL BLEEDING 41 0.0030
288 PYELONEPHRITIS 26 0.0030
289 TRANSPLANT REJECTION 24 0.0030
290 ERYSIPELAS 15 0.0030
291 TOXIC SKIN ERUPTION 30 0.0030
292 PRODUCT SIZE ISSUE 16 0.0030
293 APHTHOUS ULCER 23 0.0030
294 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 15 0.0030
295 CEREBRAL INFARCTION 72 0.0029
296 CARDIAC TAMPONADE 14 0.0029
297 ESCHERICHIA INFECTION 24 0.0029
298 GASTROINTESTINAL TOXICITY 14 0.0029
299 INTESTINAL ISCHAEMIA 16 0.0029
300 JAUNDICE 78 0.0029
301 PULMONARY ARTERIAL HYPERTENSION 42 0.0029
302 PERIORBITAL OEDEMA 15 0.0029
303 PRODUCT DOSE OMISSION ISSUE 849 0.0029
304 PULMONARY MASS 43 0.0029
305 LYMPHOCYTE COUNT DECREASED 51 0.0029
306 SEPTIC SHOCK 124 0.0028
307 HYPOXIA 100 0.0028
308 PULMONARY TOXICITY 20 0.0028
309 HEPATITIS CHOLESTATIC 17 0.0028
310 HYPERNATRAEMIA 14 0.0028
311 NEPHROGENIC ANAEMIA 13 0.0028
312 DERMATITIS EXFOLIATIVE 14 0.0028
313 HERPES SIMPLEX 18 0.0028
314 LUNG INFECTION 43 0.0028
315 URINE OUTPUT DECREASED 24 0.0027
316 ORAL CANDIDIASIS 36 0.0027
317 RENAL FAILURE CHRONIC 21 0.0027
318 SEPSIS 304 0.0027
319 INCREASED APPETITE 52 0.0027
320 RESPIRATORY DISTRESS 75 0.0027
321 BLOOD CREATININE INCREASED 177 0.0027
322 PYREXIA 936 0.0027
323 TOXIC EPIDERMAL NECROLYSIS 41 0.0027
324 STAPHYLOCOCCAL INFECTION 89 0.0027
325 RESPIRATORY FAILURE 196 0.0027
326 MALNUTRITION 30 0.0027
327 IMPAIRED HEALING 88 0.0027
328 ANGIOPATHY 15 0.0027
329 PARTIAL SEIZURES 14 0.0027
330 STOMATITIS 162 0.0027
331 HEPATITIS B 16 0.0027
332 TRICUSPID VALVE INCOMPETENCE 21 0.0026
333 MYOCARDIAL ISCHAEMIA 30 0.0026
334 STAPHYLOCOCCAL SEPSIS 13 0.0026
335 ASPARTATE AMINOTRANSFERASE INCREASED 139 0.0026
336 PNEUMONIA BACTERIAL 24 0.0026
337 BUNDLE BRANCH BLOCK RIGHT 12 0.0026
338 SKIN ATROPHY 15 0.0026
339 VENTRICULAR EXTRASYSTOLES 27 0.0026
340 ENTEROCOLITIS 15 0.0026
341 ANAL ABSCESS 14 0.0026
342 OFF LABEL USE 2256 0.0026
343 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 13 0.0026
344 MELAENA 56 0.0025
345 TERMINAL STATE 17 0.0025
346 HOSPICE CARE 25 0.0025
347 CHOLELITHIASIS 83 0.0025
348 VIRAL INFECTION 84 0.0025
349 TRANSAMINASES INCREASED 56 0.0025
350 PROTHROMBIN TIME PROLONGED 15 0.0025
351 ACUTE PULMONARY OEDEMA 14 0.0025
352 PETECHIAE 26 0.0025
353 FAECES SOFT 18 0.0025
354 ONYCHOCLASIS 17 0.0025
355 CARDIAC FAILURE 198 0.0025
356 ANAL INCONTINENCE 22 0.0024
357 CARDIOMYOPATHY 36 0.0024
358 TREATMENT NONCOMPLIANCE 132 0.0024
359 RESPIRATORY SYNCYTIAL VIRUS INFECTION 21 0.0024
360 DUODENAL ULCER 17 0.0024
361 SKIN INFECTION 27 0.0024
362 BLOOD CALCIUM DECREASED 27 0.0024
363 PERIPHERAL SENSORY NEUROPATHY 14 0.0024
364 PNEUMONIA 774 0.0024
365 HEPATIC FUNCTION ABNORMAL 89 0.0024
366 DRUG INTOLERANCE 230 0.0024
367 EJECTION FRACTION DECREASED 37 0.0024
368 IMMUNOSUPPRESSION 21 0.0024
369 ATELECTASIS 23 0.0024
370 ABDOMINAL DISCOMFORT 399 0.0024
371 PURPURA 21 0.0024
372 FAECALOMA 13 0.0024
373 MULTI-ORGAN FAILURE 41 0.0024
374 PULMONARY OEDEMA 106 0.0024
375 RENAL TUBULAR NECROSIS 23 0.0023
376 LEUKOPENIA 117 0.0023
377 NECROSIS 13 0.0023
378 BLOOD SODIUM DECREASED 44 0.0023
379 ABDOMINAL PAIN UPPER 480 0.0023
380 CARDIAC FLUTTER 15 0.0023
381 HEPATIC STEATOSIS 43 0.0023
382 BACTERIAL INFECTION 43 0.0023
383 PNEUMOCYSTIS JIROVECII PNEUMONIA 23 0.0023
384 DISEASE PROGRESSION 271 0.0023
385 RENAL IMPAIRMENT 190 0.0023
386 SUBARACHNOID HAEMORRHAGE 23 0.0023
387 HAEMATEMESIS 57 0.0022
388 OEDEMA PERIPHERAL 274 0.0022
389 MALIGNANT NEOPLASM PROGRESSION 228 0.0022
390 SHOCK HAEMORRHAGIC 18 0.0022
391 HAEMATOTOXICITY 21 0.0022
392 HYPOKALAEMIA 102 0.0022
393 PREMATURE DELIVERY 35 0.0022
394 GLOMERULAR FILTRATION RATE DECREASED 27 0.0022
395 MATERNAL EXPOSURE BEFORE PREGNANCY 15 0.0022
396 DIARRHOEA 1415 0.0022
397 DECREASED APPETITE 509 0.0022
398 NEPHROTIC SYNDROME 15 0.0022
399 SKIN LESION 60 0.0022
400 LYMPHOEDEMA 15 0.0022
401 BLOOD PRESSURE DIASTOLIC DECREASED 16 0.0022
402 OSTEONECROSIS 71 0.0022
403 NEUTROPHIL COUNT DECREASED 88 0.0022
404 NEUTROPENIA 292 0.0021
405 POST PROCEDURAL HAEMORRHAGE 25 0.0021
406 DIARRHOEA HAEMORRHAGIC 20 0.0021
407 HYPERKALAEMIA 75 0.0021
408 CHROMATURIA 48 0.0021
409 RHINITIS 17 0.0021
410 HAEMORRHAGE 220 0.0021
411 TROPONIN INCREASED 16 0.0021
412 HAEMODYNAMIC INSTABILITY 16 0.0021
413 LIVER DISORDER 93 0.0021
414 SKIN HAEMORRHAGE 31 0.0021
415 EXERCISE TOLERANCE DECREASED 12 0.0021
416 PRODUCT DOSE OMISSION IN ERROR 59 0.0021
417 RASH MACULO-PAPULAR 46 0.0021
418 MUSCULOSKELETAL CHEST PAIN 32 0.0021
419 FLUID RETENTION 105 0.0021
420 CELLULITIS 104 0.0021
421 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 35 0.0021
422 ABDOMINAL PAIN 479 0.0021
423 HYPOALBUMINAEMIA 16 0.0021
424 THERAPY INTERRUPTED 147 0.0021
425 LYMPHOPENIA 29 0.0020
426 HAEMORRHAGIC STROKE 16 0.0020
427 OEDEMA 111 0.0020
428 TORSADE DE POINTES 16 0.0020
429 ASTHENIA 766 0.0020
430 SKIN DISCOLOURATION 93 0.0020
431 GASTROINTESTINAL HAEMORRHAGE 169 0.0020
432 TRANSIENT ISCHAEMIC ATTACK 68 0.0020
433 HYPERTRANSAMINASAEMIA 14 0.0020
434 FATIGUE 1560 0.0020
435 THROMBOSIS 161 0.0020
436 RENAL DISORDER 93 0.0020
437 HEPATIC FAILURE 60 0.0020
438 GAMMA-GLUTAMYLTRANSFERASE INCREASED 44 0.0020
439 RENAL FAILURE ACUTE 84 0.0020
440 PATHOGEN RESISTANCE 18 0.0020
441 DEHYDRATION 263 0.0020
442 BLOOD MAGNESIUM DECREASED 17 0.0020
443 HEPATIC CYTOLYSIS 25 0.0020
444 SLUGGISHNESS 20 0.0020
445 PULMONARY EMBOLISM 186 0.0020
446 MENTAL STATUS CHANGES 54 0.0019
447 NAIL DISORDER 17 0.0019
448 ALANINE AMINOTRANSFERASE INCREASED 119 0.0019
449 DECREASED IMMUNE RESPONSIVENESS 19 0.0019
450 DERMATITIS BULLOUS 14 0.0019
451 ACUTE CORONARY SYNDROME 16 0.0019
452 HEPATOTOXICITY 43 0.0019
453 SKIN LACERATION 21 0.0019
454 EATING DISORDER 41 0.0019
455 GENERAL PHYSICAL CONDITION ABNORMAL 13 0.0019
456 MYELOSUPPRESSION 69 0.0019
457 TACHYPNOEA 26 0.0019
458 FLATULENCE 108 0.0019
459 BRAIN OEDEMA 24 0.0019
460 INFARCTION 13 0.0019
461 GASTRIC ULCER 36 0.0019
462 LYMPHADENOPATHY 66 0.0019
463 HYPERCHOLESTEROLAEMIA 18 0.0019
464 HERPES ZOSTER 107 0.0019
465 FLUID OVERLOAD 27 0.0019
466 CHOLECYSTITIS 22 0.0018
467 HYPONATRAEMIA 104 0.0018
468 FAECES DISCOLOURED 40 0.0018
469 ASCITES 54 0.0018
470 HEPATOCELLULAR INJURY 26 0.0018
471 HAEMOPTYSIS 51 0.0018
472 WOUND INFECTION 20 0.0018
473 TENDERNESS 19 0.0018
474 PULMONARY CONGESTION 24 0.0018
475 NEUTROPENIC SEPSIS 13 0.0018
476 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 13 0.0018
477 SPINAL COMPRESSION FRACTURE 15 0.0018
478 POOR QUALITY SLEEP 39 0.0018
479 APPETITE DISORDER 12 0.0018
480 DYSPHAGIA 171 0.0018
481 ORAL DISCOMFORT 25 0.0018
482 EYE HAEMORRHAGE 24 0.0018
483 SPINAL PAIN 21 0.0018
484 DEMENTIA 50 0.0018
485 LIVER FUNCTION TEST ABNORMAL 52 0.0018
486 RASH PUSTULAR 13 0.0018
487 INFECTION 258 0.0018
488 ABDOMINAL DISTENSION 186 0.0018
489 SUPRAVENTRICULAR TACHYCARDIA 17 0.0018
490 CONSTIPATION 387 0.0018
491 ATRIAL FIBRILLATION 172 0.0018
492 PAIN IN EXTREMITY 520 0.0018
493 RENAL CYST 14 0.0018
494 BLOOD POTASSIUM DECREASED 53 0.0018
495 PREMATURE BABY 53 0.0018
496 HEPATITIS 45 0.0018
497 ACUTE KIDNEY INJURY 269 0.0018
498 VENTRICULAR TACHYCARDIA 29 0.0018
499 VITAMIN D DECREASED 15 0.0018
500 GASTRITIS 46 0.0017
501 TEMPERATURE INTOLERANCE 18 0.0017
502 CARDIAC FAILURE CONGESTIVE 140 0.0017
503 ANURIA 15 0.0017
504 BACK PAIN 403 0.0017
505 IRON DEFICIENCY ANAEMIA 16 0.0017
506 JOINT INJURY 37 0.0017
507 C-REACTIVE PROTEIN INCREASED 63 0.0017
508 LIMB INJURY 47 0.0017
509 ILL-DEFINED DISORDER 105 0.0017
510 PNEUMONITIS 47 0.0017
511 PERICARDITIS 29 0.0017
512 PRODUCT DISTRIBUTION ISSUE 16 0.0017
513 BRAIN FOG 27 0.0017
514 POST PROCEDURAL INFECTION 14 0.0017
515 GENERAL PHYSICAL HEALTH DETERIORATION 199 0.0017
516 DECUBITUS ULCER 14 0.0017
517 HEMIPARESIS 29 0.0017
518 HEADACHE 1073 0.0017
519 POLYURIA 14 0.0017
520 HYPERTHERMIA 13 0.0017
521 ACUTE MYOCARDIAL INFARCTION 50 0.0017
522 THERAPEUTIC RESPONSE UNEXPECTED 76 0.0017
523 OCULAR DISCOMFORT 19 0.0017
524 FEELING COLD 47 0.0017
525 EMPHYSEMA 17 0.0017
526 WOUND 47 0.0017
527 ISCHAEMIC STROKE 30 0.0017
528 GASTROINTESTINAL INFECTION 15 0.0017
529 WEIGHT INCREASED 374 0.0017
530 NAUSEA 1319 0.0017
531 SCAB 19 0.0017
532 HAEMATURIA 57 0.0017
533 INTERNAL HAEMORRHAGE 19 0.0017
534 MYOCARDITIS 19 0.0017
535 SINUS BRADYCARDIA 16 0.0017
536 CHEST PAIN 306 0.0017
537 HYPERSOMNIA 47 0.0016
538 FREQUENT BOWEL MOVEMENTS 44 0.0016
539 CARDIO-RESPIRATORY ARREST 68 0.0016
540 SEASONAL ALLERGY 23 0.0016
541 DEVICE RELATED INFECTION 25 0.0016
542 VENTRICULAR FIBRILLATION 18 0.0016
543 COAGULOPATHY 27 0.0016
544 OXYGEN SATURATION DECREASED 91 0.0016
545 WEIGHT DECREASED 452 0.0016
546 PULMONARY FIBROSIS 31 0.0016
547 RESPIRATORY TRACT INFECTION 42 0.0016
548 COLON CANCER 24 0.0016
549 NEPHROPATHY 15 0.0016
550 GASTROENTERITIS VIRAL 29 0.0016
551 UPPER GASTROINTESTINAL HAEMORRHAGE 27 0.0016
552 PNEUMONIA ASPIRATION 40 0.0016
553 LACERATION 15 0.0016
554 ARTERIOSCLEROSIS 15 0.0016
555 SKIN DISORDER 53 0.0016
556 ENCEPHALOPATHY 39 0.0016
557 RASH PRURITIC 86 0.0016
558 FRACTURE 30 0.0016
559 MATERNAL EXPOSURE DURING PREGNANCY 141 0.0016
560 RENAL FAILURE 210 0.0016
561 LUNG DISORDER 77 0.0016
562 ACIDOSIS 12 0.0016
563 MALIGNANT MELANOMA 21 0.0016
564 AGRANULOCYTOSIS 29 0.0016
565 URINARY TRACT INFECTION 266 0.0016
566 DIFFUSE LARGE B-CELL LYMPHOMA 12 0.0016
567 ANOREXIA 20 0.0016
568 WHEEZING 92 0.0015
569 DIALYSIS 22 0.0015
570 ELECTROLYTE IMBALANCE 18 0.0015
571 RETCHING 33 0.0015
572 DIZZINESS POSTURAL 15 0.0015
573 CAESAREAN SECTION 18 0.0015
574 CHILLS 181 0.0015
575 FACE OEDEMA 26 0.0015
576 CANDIDA INFECTION 26 0.0015
577 ORAL HERPES 30 0.0015
578 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 84 0.0015
579 FUNGAL INFECTION 51 0.0015
580 HYPOPHAGIA 39 0.0015
581 PERIPHERAL SWELLING 234 0.0015
582 LIGAMENT SPRAIN 15 0.0015
583 ATAXIA 18 0.0015
584 INCONTINENCE 16 0.0015
585 NEOPLASM MALIGNANT 100 0.0015
586 GAIT INABILITY 50 0.0015
587 NEOPLASM PROGRESSION 52 0.0015
588 DIZZINESS 741 0.0015
589 EOSINOPHILIA 26 0.0015
590 NEPHROLITHIASIS 68 0.0015
591 FEEDING DISORDER 30 0.0015
592 DEEP VEIN THROMBOSIS 96 0.0015
593 COUGH 414 0.0015
594 CYSTITIS 47 0.0015
595 BLOOD URINE PRESENT 28 0.0015
596 THERAPY PARTIAL RESPONDER 23 0.0015
597 DISEASE RECURRENCE 70 0.0015
598 OESOPHAGITIS 16 0.0015
599 DYSPNOEA 829 0.0015
600 ASPIRATION 16 0.0015
601 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 15 0.0015
602 VOMITING 686 0.0015
603 PERIPHERAL COLDNESS 20 0.0015
604 NODULE 19 0.0015
605 URINARY INCONTINENCE 43 0.0014
606 MEMORY IMPAIRMENT 199 0.0014
607 LOCALISED INFECTION 35 0.0014
608 HYPOKINESIA 21 0.0014
609 EMBOLISM 12 0.0014
610 IMMUNE SYSTEM DISORDER 19 0.0014
611 COVID-19 PNEUMONIA 17 0.0014
612 GASTROENTERITIS 21 0.0014
613 INTERNATIONAL NORMALISED RATIO INCREASED 41 0.0014
614 INFLUENZA 160 0.0014
615 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 102 0.0014
616 PALLOR 39 0.0014
617 LIP DRY 13 0.0014
618 MASS 20 0.0014
619 HYPOCALCAEMIA 27 0.0014
620 BURNING SENSATION 100 0.0014
621 PAIN 869 0.0014
622 MALAISE 620 0.0014
623 HEAD DISCOMFORT 25 0.0014
624 UROSEPSIS 13 0.0014
625 METABOLIC ACIDOSIS 45 0.0014
626 FALL 465 0.0014
627 HIATUS HERNIA 18 0.0014
628 THERAPEUTIC RESPONSE DECREASED 84 0.0014
629 ABORTION INDUCED 13 0.0014
630 OSTEOMYELITIS 25 0.0014
631 PANCREATITIS ACUTE 31 0.0014
632 VERTIGO 84 0.0014
633 CATARACT 82 0.0014
634 SPINAL DISORDER 13 0.0014
635 BLOOD PRESSURE ABNORMAL 27 0.0014
636 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 65 0.0014
637 HYPOTENSION 271 0.0013
638 HEPATIC ENZYME INCREASED 92 0.0013
639 CARDIAC ARREST 111 0.0013
640 MUSCLE ATROPHY 17 0.0013
641 HAEMATOCHEZIA 74 0.0013
642 SINUS TACHYCARDIA 19 0.0013
643 NEPHROPATHY TOXIC 15 0.0013
644 THROMBOTIC MICROANGIOPATHY 13 0.0013
645 VITAMIN D DEFICIENCY 13 0.0013
646 SINUS CONGESTION 18 0.0013
647 ANGINA PECTORIS 38 0.0013
648 MYDRIASIS 17 0.0013
649 DRUG DOSE OMISSION 219 0.0013
650 BODY TEMPERATURE INCREASED 27 0.0013
651 LETHARGY 76 0.0013
652 RENAL PAIN 14 0.0013
653 POLLAKIURIA 55 0.0013
654 BURSITIS 16 0.0013
655 HYPERGLYCAEMIA 48 0.0013
656 MICTURITION URGENCY 15 0.0013
657 ARTHRALGIA 543 0.0013
658 ABDOMINAL PAIN LOWER 33 0.0013
659 DYSURIA 48 0.0013
660 DYSSTASIA 38 0.0013
661 INTESTINAL OBSTRUCTION 49 0.0013
662 HYPERCALCAEMIA 16 0.0013
663 ORAL PAIN 29 0.0013
664 RASH PAPULAR 29 0.0013
665 GASTROOESOPHAGEAL REFLUX DISEASE 104 0.0013
666 PHARYNGITIS 16 0.0013
667 DERMATITIS 27 0.0013
668 SARS-COV-2 TEST POSITIVE 17 0.0013
669 CEREBROVASCULAR ACCIDENT 218 0.0013
670 HAEMORRHOIDS 25 0.0013
671 DRY THROAT 13 0.0013
672 HEPATIC CIRRHOSIS 24 0.0013
673 CHRONIC KIDNEY DISEASE 97 0.0013
674 HYPERTENSION 270 0.0013
675 QUALITY OF LIFE DECREASED 17 0.0013
676 ARRHYTHMIA 60 0.0013
677 HEAD INJURY 40 0.0013
678 PROTEINURIA 24 0.0013
679 MUSCLE SPASMS 231 0.0013
680 POLYNEUROPATHY 15 0.0013
681 PALPITATIONS 146 0.0012
682 LUNG NEOPLASM MALIGNANT 51 0.0012
683 MUSCULAR WEAKNESS 141 0.0012
684 EAR PAIN 24 0.0012
685 MYALGIA 209 0.0012
686 CHOLECYSTECTOMY 14 0.0012
687 DEATH 1054 0.0012
688 COORDINATION ABNORMAL 17 0.0012
689 NEOPLASM 14 0.0012
690 GASTRIC HAEMORRHAGE 14 0.0012
691 RECTAL HAEMORRHAGE 52 0.0012
692 RESTLESS LEGS SYNDROME 22 0.0012
693 TOOTH EXTRACTION 15 0.0012
694 EYELID OEDEMA 14 0.0012
695 MUSCULOSKELETAL PAIN 63 0.0012
696 BRONCHITIS 89 0.0012
697 PHARYNGITIS STREPTOCOCCAL 13 0.0012
698 ABORTION SPONTANEOUS 48 0.0012
699 LIMB DISCOMFORT 37 0.0012
700 SOMNOLENCE 240 0.0012
701 CARDIOGENIC SHOCK 17 0.0012
702 HOSPITALISATION 181 0.0012
703 TUBULOINTERSTITIAL NEPHRITIS 22 0.0012
704 HYPERLIPIDAEMIA 14 0.0012
705 UPPER RESPIRATORY TRACT INFECTION 54 0.0012
706 DRUG INTERACTION 185 0.0012
707 LYMPHOMA 18 0.0012
708 NECK PAIN 65 0.0012
709 PRURITUS 446 0.0012
710 RASH GENERALISED 30 0.0012
711 CORONARY ARTERY DISEASE 35 0.0012
712 ALTERED STATE OF CONSCIOUSNESS 25 0.0012
713 TINNITUS 53 0.0012
714 NEURALGIA 28 0.0012
715 PREGNANCY 23 0.0011
716 DYSPEPSIA 113 0.0011
717 RASH MACULAR 40 0.0011
718 INFLAMMATION 59 0.0011
719 FEELING ABNORMAL 273 0.0011
720 ERUCTATION 22 0.0011
721 NEUROPATHY PERIPHERAL 108 0.0011
722 PANCREATITIS 60 0.0011
723 PNEUMOTHORAX 18 0.0011
724 BLINDNESS UNILATERAL 16 0.0011
725 OROPHARYNGEAL PAIN 105 0.0011
726 ABASIA 28 0.0011
727 RASH 491 0.0011
728 TACHYCARDIA 100 0.0011
729 METASTASES TO LUNG 13 0.0011
730 DIVERTICULITIS 31 0.0011
731 LIVER FUNCTION TEST INCREASED 24 0.0011
732 GASTROINTESTINAL DISORDER 100 0.0011
733 BLOOD CHOLESTEROL INCREASED 52 0.0011
734 DEAFNESS 29 0.0011
735 FOOT FRACTURE 21 0.0011
736 TOOTHACHE 20 0.0011
737 MUSCULOSKELETAL DISCOMFORT 19 0.0011
738 BALANCE DISORDER 95 0.0011
739 BONE DISORDER 20 0.0011
740 CYTOKINE RELEASE SYNDROME 22 0.0011
741 PRODUCT USE IN UNAPPROVED INDICATION 271 0.0011
742 PRODUCT ADMINISTRATION ERROR 22 0.0011
743 RASH ERYTHEMATOUS 52 0.0011
744 TREATMENT FAILURE 90 0.0011
745 UNRESPONSIVE TO STIMULI 28 0.0011
746 CONFUSIONAL STATE 175 0.0011
747 AGEUSIA 27 0.0011
748 COVID-19 189 0.0011
749 ALOPECIA 211 0.0011
750 RESPIRATORY DISORDER 32 0.0011
751 RIB FRACTURE 22 0.0011
752 CARDIAC DISORDER 100 0.0011
753 PRODUCTIVE COUGH 51 0.0011
754 SCIATICA 17 0.0011
755 DYSGEUSIA 79 0.0011
756 URINARY RETENTION 35 0.0010
757 BACK DISORDER 17 0.0010
758 HYPOAESTHESIA 156 0.0010
759 SYNCOPE 104 0.0010
760 ARTHRITIS 81 0.0010
761 APATHY 15 0.0010
762 HIP FRACTURE 33 0.0010
763 BLOOD PRESSURE SYSTOLIC INCREASED 20 0.0010
764 BLOOD PRESSURE DECREASED 68 0.0010
765 DRUG-INDUCED LIVER INJURY 32 0.0010
766 GASTRIC DISORDER 35 0.0010
767 HYPERHIDROSIS 131 0.0010
768 DRUG ERUPTION 18 0.0010
769 SWELLING 95 0.0010
770 DRY MOUTH 82 0.0010
771 CONDITION AGGRAVATED 307 0.0010
772 GALLBLADDER DISORDER 18 0.0010
773 CLOSTRIDIUM DIFFICILE INFECTION 22 0.0010
774 COLITIS 38 0.0010
775 SHOCK 23 0.0010
776 HYPOAESTHESIA ORAL 15 0.0010
777 APHASIA 30 0.0010
778 SLEEP DISORDER 70 0.0010
779 HEART RATE INCREASED 98 0.0010
780 ILLNESS 101 0.0010
781 DYSPHONIA 57 0.0010
782 NEUROTOXICITY 17 0.0010
783 PHOTOSENSITIVITY REACTION 16 0.0010
784 HYPERTHYROIDISM 14 0.0010
785 BLOOD TRIGLYCERIDES INCREASED 17 0.0010
786 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 173 0.0010
787 PHOTOPHOBIA 18 0.0010
788 ASTHMA 108 0.0010
789 HOT FLUSH 72 0.0010
790 THIRST 17 0.0010
791 BLISTER 53 0.0009
792 EAR INFECTION 25 0.0009
793 SWELLING FACE 61 0.0009
794 GAIT DISTURBANCE 179 0.0009
795 END STAGE RENAL DISEASE 17 0.0009
796 PRESCRIBED OVERDOSE 18 0.0009
797 HEART RATE IRREGULAR 21 0.0009
798 PAIN OF SKIN 25 0.0009
799 CARPAL TUNNEL SYNDROME 13 0.0009
800 CHOKING 18 0.0009
801 OSTEOPENIA 14 0.0009
802 AMNESIA 60 0.0009
803 VISUAL IMPAIRMENT 114 0.0009
804 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 48 0.0009
805 PAIN IN JAW 26 0.0009
806 KIDNEY INFECTION 18 0.0009
807 HIP ARTHROPLASTY 14 0.0009
808 FEELING HOT 56 0.0009
809 ADVERSE EVENT 84 0.0009
810 DISORIENTATION 36 0.0009
811 CHEST DISCOMFORT 93 0.0009
812 DEPRESSED MOOD 48 0.0009
813 TENDONITIS 14 0.0009
814 INSOMNIA 240 0.0009
815 TOOTH DISORDER 20 0.0009
816 FOETAL EXPOSURE DURING PREGNANCY 73 0.0009
817 NASOPHARYNGITIS 164 0.0009
818 SINUSITIS 91 0.0009
819 BRADYCARDIA 47 0.0009
820 ROAD TRAFFIC ACCIDENT 37 0.0009
821 DRUG TOXICITY 12 0.0009
822 INTENTIONAL PRODUCT MISUSE 77 0.0009
823 ACUTE HEPATIC FAILURE 12 0.0009
824 BLOOD PRESSURE FLUCTUATION 21 0.0009
825 CENTRAL NERVOUS SYSTEM LESION 12 0.0009
826 BLOOD CREATINE PHOSPHOKINASE INCREASED 25 0.0009
827 DEPRESSION 197 0.0009
828 THINKING ABNORMAL 16 0.0009
829 LOSS OF CONSCIOUSNESS 110 0.0009
830 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 25 0.0009
831 METASTASES TO LIVER 15 0.0009
832 GENERALISED TONIC-CLONIC SEIZURE 14 0.0008
833 INTENTIONAL DOSE OMISSION 24 0.0008
834 BRONCHOSPASM 12 0.0008
835 ANKLE FRACTURE 13 0.0008
836 FEMUR FRACTURE 26 0.0008
837 DELIRIUM 29 0.0008
838 DEPRESSED LEVEL OF CONSCIOUSNESS 33 0.0008
839 NASAL CONGESTION 49 0.0008
840 EYE SWELLING 31 0.0008
841 SWOLLEN TONGUE 26 0.0008
842 PRODUCT USE ISSUE 156 0.0008
843 OSTEOPOROSIS 34 0.0008
844 HEART RATE DECREASED 29 0.0008
845 MUSCLE TWITCHING 19 0.0008
846 DRY SKIN 110 0.0008
847 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 19 0.0008
848 BLOOD GLUCOSE ABNORMAL 15 0.0008
849 DIPLOPIA 21 0.0008
850 VISION BLURRED 111 0.0008
851 HALLUCINATION, VISUAL 17 0.0008
852 JOINT SWELLING 97 0.0008
853 UPPER LIMB FRACTURE 16 0.0008
854 SPINAL FRACTURE 16 0.0008
855 MOBILITY DECREASED 57 0.0008
856 BLOOD PRESSURE INCREASED 121 0.0008
857 DRUG LEVEL INCREASED 13 0.0008
858 PRESYNCOPE 19 0.0008
859 PRODUCT PRESCRIBING ISSUE 17 0.0008
860 INTERVERTEBRAL DISC PROTRUSION 17 0.0008
861 COMA 37 0.0008
862 HERNIA 15 0.0008
863 RHINORRHOEA 50 0.0008
864 OSTEONECROSIS OF JAW 19 0.0008
865 SKIN FISSURES 15 0.0008
866 PARAESTHESIA 119 0.0008
867 PRODUCT PRESCRIBING ERROR 18 0.0008
868 MEDICATION ERROR 42 0.0008
869 OSTEOARTHRITIS 32 0.0008
870 TYPE 2 DIABETES MELLITUS 25 0.0007
871 DRY EYE 37 0.0007
872 INFLUENZA LIKE ILLNESS 61 0.0007
873 LACTIC ACIDOSIS 24 0.0007
874 SKIN EXFOLIATION 62 0.0007
875 DIABETES MELLITUS 56 0.0007
876 ABNORMAL BEHAVIOUR 29 0.0007
877 HALLUCINATION 55 0.0007
878 RESPIRATORY ARREST 20 0.0007
879 JOINT STIFFNESS 19 0.0007
880 HYPOTHYROIDISM 23 0.0007
881 STEVENS-JOHNSON SYNDROME 16 0.0007
882 ARTHROPATHY 40 0.0007
883 ANXIETY 204 0.0007
884 GLOSSODYNIA 16 0.0007
885 EMOTIONAL DISORDER 22 0.0007
886 THROAT IRRITATION 32 0.0007
887 TREMOR 118 0.0007
888 GASTRIC CANCER 18 0.0007
889 MUSCULOSKELETAL STIFFNESS 62 0.0007
890 COGNITIVE DISORDER 33 0.0007
891 NERVOUS SYSTEM DISORDER 22 0.0007
892 DISCOMFORT 43 0.0007
893 DRUG INEFFECTIVE 927 0.0007
894 HYPERSENSITIVITY 130 0.0007
895 LACRIMATION INCREASED 21 0.0007
896 ADVERSE DRUG REACTION 62 0.0007
897 TASTE DISORDER 14 0.0007
898 SPEECH DISORDER 36 0.0007
899 EPILEPSY 21 0.0007
900 MOVEMENT DISORDER 22 0.0007
901 CONVULSION 39 0.0007
902 SLEEP APNOEA SYNDROME 13 0.0007
903 MIGRAINE 65 0.0007
904 MYOCARDIAL INFARCTION 117 0.0007
905 CARDIOVASCULAR DISORDER 17 0.0007
906 DISTURBANCE IN ATTENTION 36 0.0007
907 AGITATION 49 0.0007
908 PLASMA CELL MYELOMA 26 0.0007
909 ERECTILE DYSFUNCTION 17 0.0007
910 LOWER RESPIRATORY TRACT INFECTION 30 0.0007
911 EYE PAIN 37 0.0007
912 INCORRECT DOSE ADMINISTERED 149 0.0007
913 ERYTHEMA 134 0.0007
914 PRESCRIBED UNDERDOSE 13 0.0007
915 HYPOACUSIS 28 0.0006
916 DRUG EXPOSURE DURING PREGNANCY 22 0.0006
917 PRODUCT PHYSICAL ISSUE 13 0.0006
918 PRODUCT DISPENSING ERROR 14 0.0006
919 HYPOGLYCAEMIA 31 0.0006
920 MENTAL IMPAIRMENT 15 0.0006
921 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 44 0.0006
922 IRRITABILITY 37 0.0006
923 SURGERY 36 0.0006
924 URTICARIA 102 0.0006
925 SEIZURE 70 0.0006
926 RENAL INJURY 18 0.0006
927 INFUSION RELATED REACTION 40 0.0006
928 PRURITUS GENERALISED 13 0.0006
929 DYSKINESIA 24 0.0006
930 BLINDNESS 24 0.0006
931 SNEEZING 13 0.0006
932 NERVOUSNESS 30 0.0006
933 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 115 0.0006
934 COLITIS ULCERATIVE 25 0.0006
935 EYE DISORDER 18 0.0005
936 EXPOSURE DURING PREGNANCY 34 0.0005
937 ACCIDENTAL OVERDOSE 20 0.0005
938 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 14 0.0005
939 VISUAL ACUITY REDUCED 18 0.0005
940 ACNE 41 0.0005
941 PROCEDURAL PAIN 15 0.0005
942 DYSARTHRIA 19 0.0005
943 WITHDRAWAL SYNDROME 21 0.0005
944 ECZEMA 26 0.0005
945 MOOD ALTERED 13 0.0005
946 ABNORMAL DREAMS 13 0.0005
947 MOOD SWINGS 15 0.0005
948 RESTLESSNESS 17 0.0005
949 OCULAR HYPERAEMIA 22 0.0005
950 MENTAL DISORDER 20 0.0005
951 SKIN IRRITATION 21 0.0005
952 RHEUMATOID ARTHRITIS 52 0.0005
953 EXPIRED PRODUCT ADMINISTERED 15 0.0005
954 SYSTEMIC LUPUS ERYTHEMATOSUS 16 0.0005
955 PANCREATIC CARCINOMA 13 0.0004
956 ANGER 15 0.0004
957 WRONG TECHNIQUE IN DRUG USAGE PROCESS 16 0.0004
958 CONTRAINDICATED PRODUCT ADMINISTERED 13 0.0004
959 UNDERDOSE 31 0.0004
960 DRUG ADMINISTRATION ERROR 13 0.0004
961 UNEVALUABLE EVENT 32 0.0004
962 TOXICITY TO VARIOUS AGENTS 71 0.0004
963 LIP SWELLING 14 0.0004
964 EYE IRRITATION 24 0.0004
965 FLUSHING 41 0.0004
966 BLOOD GLUCOSE INCREASED 74 0.0004
967 CRYING 14 0.0004
968 ANGIOEDEMA 17 0.0004
969 AGGRESSION 19 0.0004
970 VAGINAL HAEMORRHAGE 15 0.0003
971 INJURY 24 0.0003
972 PROSTATE CANCER 27 0.0003
973 THERAPEUTIC PRODUCT EFFECT DECREASED 15 0.0003
974 PRODUCT SUBSTITUTION ISSUE 19 0.0003
975 BREAST CANCER 30 0.0003
976 EXTRA DOSE ADMINISTERED 13 0.0003
977 BLOOD GLUCOSE DECREASED 15 0.0003
978 EMOTIONAL DISTRESS 36 0.0003
979 SUICIDAL IDEATION 26 0.0003
980 OVERDOSE 57 0.0003
981 SKIN BURNING SENSATION 18 0.0003
982 ANAPHYLACTIC REACTION 13 0.0002
983 BLADDER CANCER 13 0.0002
984 NO ADVERSE EVENT 39 0.0002
985 PRODUCT STORAGE ERROR 18 0.0002
986 PRODUCT QUALITY ISSUE 27 0.0002
987 INJECTION SITE BRUISING 15 0.0002
988 INJECTION SITE ERYTHEMA 21 0.0002
989 DEVICE ISSUE 13 0.0001
990 PSORIASIS 17 0.0001
991 INJECTION SITE PAIN 39 0.0001
992 DRUG DEPENDENCE 15 0.0001